Lilu Guo

560 total citations
7 papers, 150 citations indexed

About

Lilu Guo is a scholar working on Physiology, Neurology and Organic Chemistry. According to data from OpenAlex, Lilu Guo has authored 7 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Neurology and 2 papers in Organic Chemistry. Recurrent topics in Lilu Guo's work include Lysosomal Storage Disorders Research (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Lilu Guo is often cited by papers focused on Lysosomal Storage Disorders Research (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Lilu Guo collaborates with scholars based in United States, Norway and Mexico. Lilu Guo's co-authors include Ross C. Gruber, Fabrizio Pontarelli, Alexei Degterev, Cheng Zhu, Pontus Ørning, Dimitry Ofengeim, Amy Mahan, Lisa Woodworth, Matija Zelic and Yi Ren and has published in prestigious journals such as PLoS ONE, Cell Reports and eLife.

In The Last Decade

Lilu Guo

6 papers receiving 144 citations

Peers

Countries citing papers authored by Lilu Guo

Since Specialization

Citations

This map shows the geographic impact of Lilu Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilu Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilu Guo more than expected).

Fields of papers citing papers by Lilu Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilu Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilu Guo. The network helps show where Lilu Guo may publish in the future.

Co-authorship network of co-authors of Lilu Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Lilu Guo. A scholar is included among the top collaborators of Lilu Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilu Guo. Lilu Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Comparative outcomes of laparoscopic lateral suspension, sacrocolpopexy, and transvaginal mesh for advanced apical prolapse: A retrospective cohort study 2025 ·PLoS ONE ·Lilu Guo, Xiaodi Li, Huihua Li, (unknown), (unknown), Jingni Wu	0
2	Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicity 2024 ·Communications Biology ·(unknown), Disha Sood, Lilu Guo, Michael R. Dufault, Mariana Garcı́a, (unknown), (unknown), Bailin Zhang, James C. Dodge	5
3	Anti-human-TfR-GAA efficiently clears CNS and muscle glycogen in a translatable hTfR-KI/Pompe disease mouse model 2024 ·Molecular Genetics and Metabolism ·Arjan van der Flier, (unknown), Laurie D. Smith, (unknown), Shan Zhou, Elena Kistanova, (unknown), Lilu Guo, (unknown), Caroline Morel, Dinesh S. Bangari, Kristina An Haack, (unknown)	1
4	Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center 2023 ·eLife ·(unknown), (unknown), Jiapeng Ruan, (unknown), (unknown), Glenn S. Belinsky, Amir Akhavan, Andrew Lischuk, Lilu Guo, K. Klinger, Pramod K. Mistry	7
5	Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy 2022 ·eLife ·Chandra Sekhar Boddupalli, Shiny Nair, Glenn S. Belinsky, Joseph Gans, Erin Teeple, Tri‐Hung Nguyen, Sameet Mehta, Lilu Guo, Martin Kramer, Jiapeng Ruan, (unknown), Matt Davison, Dinesh Kumar, D. J. Vidyadhara, Bailin Zhang, K. Klinger, Pramod K. Mistry	33
6	Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease 2021 ·Molecular Genetics and Metabolism Reports ·(unknown), Jiapeng Ruan, (unknown), Bailin Zhang, (unknown), Haiqun Lin, Lilu Guo, K. Klinger, Pramod K. Mistry	14
7	RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis 2021 ·Cell Reports ·Matija Zelic, Fabrizio Pontarelli, Lisa Woodworth, Cheng Zhu, Amy Mahan, Yi Ren, (unknown), Ross C. Gruber, (unknown), (unknown), Lilu Guo, (unknown), (unknown), Pontus Ørning, Egil Lien, Alexei Degterev, Timothy R. Hammond, Dimitry Ofengeim	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact